Gilead Sciences: persistent sell signal but strength at its lowest

Gilead Sciences is at week 10 of a sell signal with strength that our model measures at just 4 out of 100 — near the bottom of the category. The Healthcare sector is in a positive regime (+2.1% in recent weeks), and the stock shows a double bottom near the 128 area with an 8% intermediate rebound. Our model advises against opening new short positions under these conditions.